Treating hypertension in Black patients
- PMID: 35076435
- DOI: 10.1097/01.JAA.0000791512.37549.64
Treating hypertension in Black patients
Abstract
For the first time in its history, the Eighth Joint National Committee (JNC-8) published hypertension guidelines that varied depending on patient race, with different treatment recommendation for Black and non-Black patients. Although initial therapy in non-Black patients is to be carried out with one of four agents-thiazide diuretics, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, or angiotensin receptor blockers (ARBs)-the recommendation for Black patients removed ACE inhibitors and ARBs from the algorithm. This article reviews some of the physiologic theories for the difference in recommendations and discusses potential complications with race-based treatment algorithms.
Copyright © 2022 American Academy of Physician Assistants.
References
-
- Flynn JT, Kaelber DC, Baker-Smith CM, et al. Clinical practice guideline for screening and management of high blood pressure in children and adolescents. Pediatrics . 2017;140(3):e20171904.
-
- Whelton PK, Carey RM, Aronow WS, et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension . 2018;71(6):1269–1324.
-
- Williams SK, Ravenell J, Seyedali S, et al. Hypertension treatment in Blacks: discussion of the U.S. clinical practice guidelines. Prog Cardiovasc Dis . 2016;59(3):282–288.
-
- Rodriguez F, Ferdinand KC. Hypertension in minority populations: new guidelines and emerging concepts. Adv Chronic Kidney Dis . 2015;22(2):145–153.
-
- Feldman H, Zuber K, Davis JS. Staying up to date with the JNC 8 hypertension guideline. JAAPA . 2014;27(8):44–49.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous